Eur J Prev Cardiol 31:12601273 Hankosky ER, Wang H, Neff LM et al (2024) Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis
An Overlooked Risk: Toxicity Fears Hiding Subclinical Deficiency Concerns over vitamin A toxicity, particularly during pregnancy, have led to a focus on avoiding excess while neglecting deficiency risks, especially mild or marginal deficiencies that may disrupt brain development without obvious clinical signs [10]
As of writing, retatrutide is still in Phase 3 trials
Its not for human consumption
The formulation appears to support metabolic function and energy production, which has been helpful in maintaining consistency with diet and activity levels
Our team at Well-Rooted will guide you through the best approach for your specific health concerns